Tower Research Capital (TRC)’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-7,657
| Closed | -$88K | – | 6042 |
|
|
2020
Q4 | $88K | Sell |
7,657
-12,834
| -63% | -$147K | ﹤0.01% | 2483 |
|
|
2020
Q3 | $141K | Buy |
20,491
+13,912
| +211% | +$95.7K | ﹤0.01% | 2873 |
|
|
2020
Q2 | $43K | Buy |
+6,579
| New | +$43K | ﹤0.01% | 3172 |
|
|
2019
Q4 | – | Sell |
-8,705
| Closed | -$55K | – | 4773 |
|
|
2019
Q3 | $55K | Buy |
8,705
+6,759
| +347% | +$42.7K | ﹤0.01% | 1736 |
|
|
2019
Q2 | $14K | Sell |
1,946
-2,894
| -60% | -$20.8K | ﹤0.01% | 2392 |
|
|
2019
Q1 | $30K | Buy |
4,840
+644
| +15% | +$3.99K | ﹤0.01% | 2056 |
|
|
2018
Q4 | $48K | Buy |
+4,196
| New | +$48K | ﹤0.01% | 1319 |
|
|
2018
Q3 | – | Sell |
-1,025
| Closed | -$16K | – | 4469 |
|
|
2018
Q2 | $16K | Buy |
1,025
+579
| +130% | +$9.04K | ﹤0.01% | 2569 |
|
|
2018
Q1 | $8K | Buy |
446
+37
| +9% | +$664 | ﹤0.01% | 2572 |
|
|
2017
Q4 | $7K | Sell |
409
-291
| -42% | -$4.98K | ﹤0.01% | 2776 |
|
|
2017
Q3 | $10K | Buy |
+700
| New | +$10K | ﹤0.01% | 3093 |
|
|
2017
Q2 | – | Sell |
-432
| Closed | -$7K | – | 3883 |
|
|
2017
Q1 | $7K | Sell |
432
-72
| -14% | -$1.17K | ﹤0.01% | 2049 |
|
|
2016
Q4 | $11K | Sell |
504
-366
| -42% | -$7.99K | ﹤0.01% | 2607 |
|
|
2016
Q3 | $16K | Buy |
870
+822
| +1,713% | +$15.1K | ﹤0.01% | 1759 |
|
|
2016
Q2 | $1K | Buy |
+48
| New | +$1K | ﹤0.01% | 4271 |
|